• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 834-848 of 1,230 results

1061 Exhibit: DUPONT��� TYVEK�� COMPLIANCE TO ISO 11607 12006 2011

Document IPR2021-00816, No. 1061-70 Exhibit - DUPONT��� TYVEK�� COMPLIANCE TO ISO 11607 12006 2011 (P.T.A.B. Apr. 16, 2021)

cite Cite Document
Analyze

2126 Exhibit: Ex 2126 NOVITCCH00054063 Public Redacted Version

Document IPR2021-00816, No. 2126-468 Exhibit - Ex 2126 NOVITCCH00054063 Public Redacted Version (P.T.A.B. Jan. 19, 2022)

cite Cite Document
Analyze

2166 Exhibit: Ex 2166 NOVITCUS00389194 Public Redacted Version

Document IPR2021-00816, No. 2166-442 Exhibit - Ex 2166 NOVITCUS00389194 Public Redacted Version (P.T.A.B. Jan. 19, 2022)

cite Cite Document
Analyze

2058 Exhibit: 2058

Document IPR2021-00816, No. 2058-153 Exhibit - 2058 (P.T.A.B. Jul. 28, 2021)

cite Cite Document
Analyze

2008 Exhibit: 2008

Document IPR2021-00816, No. 2008-108 Exhibit - 2008 (P.T.A.B. Jul. 28, 2021)

cite Cite Document
Analyze

1003 Exhibit: Declaration of Horst Koller under 37 CFR �� 168

Document IPR2021-00816, No. 1003-6 Exhibit - Declaration of Horst Koller under 37 CFR �� 168 (P.T.A.B. Apr. 16, 2021)

cite Cite Document
Analyze

1039 Exhibit: Internet Archive WayBack Machine, February 25, 2011 Record of Dru...

Document IPR2021-00816, No. 1039-48 Exhibit - Internet Archive WayBack Machine, February 25, 2011 Record of Drugscom, FDA Professional Drug Information (P.T.A.B. Apr. 16, 2021)

cite Cite Document
Analyze

1032 Exhibit: Curriculum Vitae of Dr Szilard Kiss

Document IPR2021-00816, No. 1032-41 Exhibit - Curriculum Vitae of Dr Szilard Kiss (P.T.A.B. Apr. 16, 2021)

cite Cite Document
Analyze

1085 Exhibit: ITC Investigation No 337 TA 1207, Statement on the Public Interest b...

Document IPR2021-00816, No. 1085-95 Exhibit - ITC Investigation No 337 TA 1207, Statement on the Public Interest by Proposed Respondent Regeneron Pharmaceuticals, Inc (P.T.A.B. Apr. 16, 2021)

cite Cite Document
Analyze

2269 Exhibit: Ex 2269 FDA Approves Eylea Article

Document IPR2021-00816, No. 2269-407 Exhibit - Ex 2269 FDA Approves Eylea Article (P.T.A.B. Jan. 19, 2022)

cite Cite Document
Analyze

2273 Exhibit: Ex 2273 Roche Finance Report for 2011

Document IPR2021-00816, No. 2273-411 Exhibit - Ex 2273 Roche Finance Report for 2011 (P.T.A.B. Jan. 19, 2022)

cite Cite Document
Analyze

2171 Exhibit: Ex 2171 NOVITCUS00697489 Public Redacted Version

Document IPR2021-00816, No. 2171-447 Exhibit - Ex 2171 NOVITCUS00697489 Public Redacted Version (P.T.A.B. Jan. 19, 2022)

cite Cite Document
Analyze

2156 Exhibit: Ex 2156 NOVITCUS00006173 Public Redacted Version

Document IPR2021-00816, No. 2156-436 Exhibit - Ex 2156 NOVITCUS00006173 Public Redacted Version (P.T.A.B. Jan. 19, 2022)

cite Cite Document
Analyze

2264 Exhibit: Ex 2264 Roche March 22, 2018 Investor Update

Document IPR2021-00816, No. 2264-404 Exhibit - Ex 2264 Roche March 22, 2018 Investor Update (P.T.A.B. Jan. 19, 2022)

cite Cite Document
Analyze

2144 Exhibit: Ex 2144 NOVITCCH01498292 PUBLIC REDACTED VERSION

Document IPR2021-00816, No. 2144-428 Exhibit - Ex 2144 NOVITCCH01498292 PUBLIC REDACTED VERSION (P.T.A.B. Jan. 19, 2022)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 56 57 58 59 60 ... >>